Occidental Petroleum Explores OxyChem Divestiture Amidst Debt Reduction Strategy

Occidental Petroleum Eyes OxyChem Divestment for Debt Reduction

Occidental Petroleum (NYSE: OXY) is reportedly pursuing the divestment of its OxyChem petrochemical business for an estimated $10 billion, a strategic move aimed at substantially reducing the company's debt burden. The potential sale marks a significant shift in the energy major's portfolio, with an announcement anticipated in the coming weeks.

The Proposed Sale and Debt Reduction Strategy

The proposed $10 billion sale of OxyChem, which would potentially create one of the world's largest independent petrochemical units, is central to Occidental's aggressive debt reduction strategy. The company accumulated significant debt through key acquisitions, notably the $55 billion purchase of Anadarko Petroleum in 2019 and the $12 billion acquisition of CrownRock in 2023. As of June 30, 2025, Occidental's long-term debt stood at $23.34 billion. Following the CrownRock deal, Occidental has already divested over $4 billion in assets and repaid $7.5 billion in debt since July 2024, surpassing its initial target of $4.5 billion to $6 billion in asset sales.

Market Reaction and Analyst Perspectives

Initial market reaction to the news indicated a positive sentiment, with OXY shares rising premarket by over 1%, as investors viewed the potential sale as a favorable step towards balance sheet normalization. Barclays noted that the divestment "would accelerate balance sheet normalization and position the company to increase cash returns." However, some analysts, including one cited by Seeking Alpha, have tempered their outlook, downgrading OXY to 'Hold' due to the anticipated shift in business mix. This shift would render Occidental more exposed to oil price volatility and reduce its portfolio diversification, potentially altering its risk profile.

Broader Context and Financial Implications

The decision to divest OxyChem arrives amidst a challenging period for the petrochemicals industry, which has experienced declining profits due to oversupply from new capacity in the U.S. and Middle East, alongside increased output from China. While OxyChem has historically provided stable cash flow, its sale underscores Occidental's commitment to streamlining operations and improving capital efficiency. Financially, Occidental reported Q3 2025 earnings per share of $0.39 on revenues of $6.41 billion, both exceeding consensus estimates. Despite a current ratio of 1.05 and an EBITDA margin of 45.98%, the company's Altman Z-Score of 1.46 places it in a 'distress zone,' indicating potential near-term bankruptcy risk, highlighting the urgency of debt reduction. Furthermore, Occidental continues to address its preferred share obligations, notably the $10 billion investment from Warren Buffett's Berkshire Hathaway in 2019, which carries an 8% annual dividend. As of March 31, 2024, approximately $1.5 billion of this preferred stock had been redeemed, with further redemptions tied to the company's ability to return excess cash to shareholders.

Expert Commentary

Barclays emphasized that this move would represent a "strategic change for OXY, but would clearly accelerate deleveraging and the transition to higher cash returns, developments we believe would be viewed positively by the market." The bank further projected OxyChem's EBITDA at approximately $1.24 billion in 2025, rising to $1.46 billion by 2027, with the $10 billion headline price implying a roughly 7x 2026–2027 estimated EBITDA multiple.

Outlook: A More Focused Energy Producer

Should the sale proceed, Occidental Petroleum would emerge as a more pure-play oil and gas entity, with its financial health significantly improved by a reduced debt load, potentially below the $15 billion target. This shift, however, positions the company with heightened sensitivity to global oil price fluctuations, impacting its overall risk profile. Investors will closely monitor the finalization of the OxyChem divestiture and its subsequent impact on Occidental's long-term strategic direction, particularly concerning its deleveraging trajectory and capital allocation policies.